10.10.2011 • NewsKenneth FrazierRichard ClarkPeople

Kenneth Frazier To Succeed Richard Clark as Merck & Co. Chair

Merck and Co. announced the retirement of its Chairman Richard Clark, effective Dec. 1. Kenneth Frazier, president of chief executive officer will succeed as chairman.

Clark has been with the company since 1972 and served as chairman since 2007. He was president and chief executive officer from 2005 through 2010. From the role of quality control inspector, he progressed through increasingly responsible roles. He left the company to join Merck-Medco Managed Care subsidiary as executive vice president and chief operating officer. He later became the chairman, president and chief executive officer of Medco Health Solutions. In 2003 Clark rejoined Merck as president of manufacturing division.

 

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences

The Start-up Platform for Chemistry & Life Sciences

The tasks range from employee protection, site security and crisis management to IT, OT and production security.

Free Virtual Event

ProteiNext 2025

ProteiNext 2025

ProteiNext is an annual symposium that offers a platform for sharing insights on protein analysis

most read

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.

Photo
27.03.2025 • News

J&J to Invest $55 Billion in US Operations

US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.